Global  

Novacyt S.A. ("Novacyt", the "Company" or the “Group”): Half Year 2020 Results

Business Wire Thursday, 17 September 2020
PARIS & CAMBERLEY, England--(BUSINESS WIRE)--Regulatory News: Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited results for the six months ended 30 June 2020 and provides an update on its growth strategy. Summary highlights H1 2020 sales of €72.4 million and EBITDA of €49.4 million, resulting from the sale of the Company’s market leading PCR COVID-19 test, has transformed Novacyt Performance provides period end cash of €19.7m, fo
0
shares
ShareTweetSavePostSend
 

You Might Like


Related news from verified sources

Marie Brizard Wine & Spirits: postponement of the publication of the half year results until 30th September 2020

Paris, 18^th September 2020 *Postponement of the publication of the half year results until 30^th September 2020* *Marie Brizard Wine and Spirits (Euronext...
GlobeNewswire Also reported by •EQS Group

Guerbet: 2020 Half-year results

* * *2020 half-year results* ** · *Revenue affected by the COVID crisis* · -9.2% at current exchange rates at €363.7 million · -8.4% at...
GlobeNewswire Also reported by •EQS GroupBusiness Wire

2020 Half-Year Results for CARBIOS, the World Leader in Biorecycling and Biodegrading Plastics

2020 Half-Year Results for CARBIOS, the World Leader in Biorecycling and Biodegrading Plastics
CLERMONT-FERRAND, France--(BUSINESS WIRE)--2020 Half-Year Results for CARBIOS, the world leader in biorecycling and biodegrading plastics
Business Wire


Tweets about this